Why BioNTech's Stock Is Trading Higher Today

BioNTech BNTX shares are trading higher following news the company and Pfizer initiated a Biologics License Application with the FDA for approval of their mRNA vaccine. German government officials on Thursday also came out in opposition to Biden's plan to suspend COVID-19 vaccine patents, which has also helped lift the stock.

BioNTech's stock is trading up 7.15% to a price of $180.2. The stock's current volume for the day is 3.56 million, which is approximately 104.13% of its previous 30-day average volume of 3.42 million.

The stock's 50-day moving average was $126.98 at the time this article was published. Over the past fifty-two weeks, the price has risen as high as $213.15 and fallen to a low of $45.08.

If you're looking for timely and concise explanations of why a stock is moving, check out Benzinga Pro. Subscribers get ‘Why Is It Moving' alerts as soon as our research team identifies the cause of the price action in a stock. Click here to learn more.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Trading IdeasBZI-WIIM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!